Unique ID issued by UMIN | UMIN000017274 |
---|---|
Receipt number | R000020047 |
Scientific Title | A Study for Evaluating the Effects of Oral Intake of Lactic Acid Bacteria on Pathogenesis of Common Cold and Influenza-like Illness. |
Date of disclosure of the study information | 2015/04/25 |
Last modified on | 2015/04/25 12:03:12 |
A Study for Evaluating the Effects of Oral Intake of Lactic Acid Bacteria on Pathogenesis of Common Cold and Influenza-like Illness.
A Study for Evaluating the Effects of Oral Intake of Lactic Acid Bacteria on Pathogenesis of Common Cold and Influenza-like Illness.
A Study for Evaluating the Effects of Oral Intake of Lactic Acid Bacteria on Pathogenesis of Common Cold and Influenza-like Illness.
A Study for Evaluating the Effects of Oral Intake of Lactic Acid Bacteria on Pathogenesis of Common Cold and Influenza-like Illness.
Japan |
Healthy adult
Not applicable | Adult |
Others
NO
Evaluating the Effects of Oral Intake of Lactic Acid Bacteria on Pathogenesis of Common Cold and Influenza-like Illness and Immunological Response to Influenza Virus.
Efficacy
Daily questionnaire symptoms based on influenza-like illness
Immunological test using bloods collected before and after the intake period (10 weeks)
Interventional
Parallel
Randomized
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Lactic acid bacteria, 10 weeks consumption.
Placebo (not containing lactic acid bacteria), 10 weeks consumption
30 | years-old | <= |
60 | years-old | > |
Male and Female
(1)Subjects aged 30 to 60 years old.
(2)Subjects giving written informed consent.
(1)Subjects who are judged as unsuitable for the study by the investigator for the other reasons.
(2)Subjects taking any kind of medicine which affect the result of the trial for habitual use.
(3)Subjects daily consuming supplements or foods containing lactic acid bacteria.
(4)Pregnant women, lactating women.
(5)Alcoholics
(6)Subjects presenting known food allergy (milk allergy) and serious hay fever.
(7)Subjects attending other tests.
(8)Subjects with serious hepatic, renal, and cardiovascular dysfunction (including anamnesis).
(9)Subjects with anemic.
(10)Subjects who had received the influenza vaccination within the previous 18 months.
200
1st name | |
Middle name | |
Last name | Takashi Koikeda |
Shiba Palace Clinic
Chair
6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
03-5408-1590
jimukyoku@mail.souken-r.com
1st name | |
Middle name | |
Last name | Ko Masuda |
SOUKEN Co., Ltd
Management Division
3F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
03-5408-1555
k_masuda@mail.souken-r.com
Shiba Palace Clinic
Kirin Co., Ltd.
Profit organization
NO
芝パレスクリニック(東京都)
2015 | Year | 04 | Month | 25 | Day |
Unpublished
Completed
2012 | Year | 11 | Month | 01 | Day |
2012 | Year | 12 | Month | 01 | Day |
2015 | Year | 04 | Month | 25 | Day |
2015 | Year | 04 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020047
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |